Temozolomide

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12371 publications

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 14, 2026

Mutant p53 Directs PARP to Regulate Replication Stress and Drive Breast Cancer Metastasis.

Mutant p53 Directs PARP to Regulate Replication Stress and Drive Breast Cancer Metastasis.

Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026

Heterogenous Model of Temozolomide Resistance in Glioblastoma Reveals Phenotypic Shifts in Drug Response and Migratory Potential.

Heterogenous Model of Temozolomide Resistance in Glioblastoma Reveals Phenotypic Shifts in Drug Response and Migratory Potential.

Journal: Advanced nanobiomed research
Published: April 02, 2026

DNA Repair Enzyme Regulation Strategy for Enhanced Pancreatic Neuroendocrine Tumor Therapy via Targeting siRNA-Lipid Nanoparticles.

DNA Repair Enzyme Regulation Strategy for Enhanced Pancreatic Neuroendocrine Tumor Therapy via Targeting siRNA-Lipid Nanoparticles.

Journal: ACS nano
Published: April 01, 2026

Discovery, Optimization, and Biological Evaluation of 2-Cyano-2-(9H-xanthen-9-ylidene)acetamide Derivatives as ZNF207 Inhibitors for Anti-Glioma Therapy.

Discovery, Optimization, and Biological Evaluation of 2-Cyano-2-(9H-xanthen-9-ylidene)acetamide Derivatives as ZNF207 Inhibitors for Anti-Glioma Therapy.

Journal: Journal of medicinal chemistry
Published: March 19, 2026

Synergistic Effects of Curcumin and Temozolomide in Overcoming Glioblastoma Drug Resistance through Regulation of O6-Methylguanine-DNA Methyltransferase, Mismatch Repair, and Poly(Adenosine Diphosphate Ribose) Polymerase 1.

Synergistic Effects of Curcumin and Temozolomide in Overcoming Glioblastoma Drug Resistance through Regulation of O6-Methylguanine-DNA Methyltransferase, Mismatch Repair, and Poly(Adenosine Diphosphate Ribose) Polymerase 1.

Journal: Drug research
Published: March 17, 2026

Pneumocystis jirovecii pneumonia in a chemotherapy-induced immunocompromised patient with glioblastoma multiforme.

Pneumocystis jirovecii pneumonia in a chemotherapy-induced immunocompromised patient with glioblastoma multiforme.

Journal: BMJ case reports
Published: March 16, 2026

Retraction Note: Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway.

Retraction Note: Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway.

Journal: Cancer chemotherapy and pharmacology
Published: March 16, 2026

Mismatch repair deficiency reshapes glioblastoma through immune suppression rather than hypermutation.

Mismatch repair deficiency reshapes glioblastoma through immune suppression rather than hypermutation.

Journal: The Journal of clinical investigation
Published: March 16, 2026

The Size of Glioblastoma Spheroids Influences Patterns of Invasion and Temozolomide Efficacy.

The Size of Glioblastoma Spheroids Influences Patterns of Invasion and Temozolomide Efficacy.

Journal: Tissue engineering. Part C, Methods
Published: March 16, 2026

Standard-of-Care Treatment of Glioblastoma: Out-of-Pocket Cost Modeling of Adjuvant Radiation Therapy Duration Across Current-Year Medicaid and Medicare Plans.

Standard-of-Care Treatment of Glioblastoma: Out-of-Pocket Cost Modeling of Adjuvant Radiation Therapy Duration Across Current-Year Medicaid and Medicare Plans.

Journal: American journal of clinical oncology
Published: March 13, 2026

Xihuang Pills induce mitochondria-associated ferroptosis to enhance therapeutic efficacy of temozolomide against glioblastoma via Nrf2/HO-1/GPX4 signaling axis

Xihuang Pills induce mitochondria-associated ferroptosis to enhance therapeutic efficacy of temozolomide against glioblastoma via Nrf2/HO-1/GPX4 signaling axis

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: March 12, 2026
Showing 1-12 of 12,371

Last Updated: 04/28/2026